Checkpoint Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
75.60
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.47
|
-1.20
|
0.27
|
18.37%
|
|
2022-06-30
|
-1.72
|
-1.60
|
0.12
|
6.98%
|
|
2022-03-31
|
-1.42
|
-2.00
|
-0.58
|
-40.85%
|
|
2021-12-31
|
-1.54
|
-3.90
|
-2.36
|
-153.25%
|
|
2021-09-30
|
-1.36
|
-1.40
|
-0.04
|
-2.94%
|
|
2021-06-30
|
-1.04
|
-1.20
|
-0.16
|
-15.38%
|
|
2021-03-31
|
-1.05
|
-0.90
|
0.15
|
14.29%
|
|
2020-12-31
|
-0.80
|
-1.70
|
-0.90
|
-112.50%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.80
|
|
2021-12-31
|
-7.40
|
|
2020-12-31
|
-1.94
|
|
2019-12-31
|
-0.70
|
|
2018-12-31
|
-1.28
|
|
2017-12-31
|
-1.00
|
|
2016-12-31
|
-0.34
|